Their clinical and translational research program has developed Dbait molecules now in Phase I clinical trial in patients with advanced melanoma
Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and DNA Therapeutics, a biopharmaceutical…
Curie-Cancer, DNA Therapeutics renew partnership to identify new class of cancer drugs
No comments:
Post a Comment